Akram, O.N, Bernier, A., Petrides, F., Wong, G. and Lambert, G. (2010) Beyond LDL Cholesterol, a new role for PCSK9. Arterioscler Thromb Vasc Biol. 30(7):1279-1281.

1. Arsenault, B.J., Barter, P., Demicco, D.A., Bao, W., Preston, G.M., Larosa, J.C., Grundy, S.M., Deedwania, P., Greten, H., Wenger, N.K., Shepherd, J., Waters, D.D. and Kastelein, J.J.; TNT Study Investigators. (2010) Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and non-lipid biomarkers. J Am Coll Cardiol. 57(1): 63-69.
2. Ayer, J.G., Harmer, J.A,. Marks, G.B., Avolio, A. and Celermajer, D.S. (2010) Central arterial pulse wave augmentation is greater in girls than boys, independent of height. J Hypertens 28 (2): 306-313.
3. Ayer, J.G., Harmer, J.A., Steinbeck, K. and Celermajer, D.S. (2010) Postprandial vascular reactivity in obese and normal weight young adults. Obesity (Silver Spring). 18(5): 945-951. View Abstract.
4. Ayer, J.G., Song, C., Steinbeck, K., Celermajer, D.S. and Freedman, S.B. (2010) Increased tissue factor activity in monocytes from obese young adults. Clin Exp Pharmacol Physiol. 37(11): 1049-1054.
5. Barter, P.J.(2010) The relationship between cholesteryl ester transfer protein and cardiovascular risk. Clin Chem. 56(10): 1547-1549.
6. Barter, P.J., Brandrup-Wognsen, G., Palmerm M.K. and Nicholls, S.J. (2010) Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. J Lipid Res 51(6): 1546-1553.
7. Balasuriya, H., Bell, P., Waugh, R., Thompson, J., Gillin, A., Hennessy, A. and Makris, A. (2010) Primate maternal placental angiography. Placenta 31 (1): 32-36.
8. Beck, K., Wu, B.J., Santiago, F.S., Malabanan, K.P., Li, C., Wang, Y., Khachigian, L.M. and Stocker, R. (2010) Interplay between heme oxygenase-1 and the multifunctional transcription factor Yin Yang 1 in the inhibition of intimal hyperplasia. Circ Res. 107(12): 1490-1497.
9. Bursill, C.A., Castro, M.L., Beattie, D.T., Nakhla, S., van der Vorst, E., Heather, A.K., Barter, P.J. and Rye, K.A. (2010) High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler Thromb Vasc Biol. 30(9); 1773-1778.
10. Byrom, M.J., Bannon, P.G., White, G.H. and Ng, M.K. (2010) Animal models for the assessment of novel vascular conduits. J Vasc Surg. 52 (1): 176-195.
11. Cannon, C.P., Shah, S., Dansky, H.M., Davidson, M., Brinton, E.A., Gotto, A.M., Stepanavage, M., Liu, S.X., Gibbons, P., Ashraf, T.B., Zafarino, J., Mitchel, Y. and Barter, P.J. ; the DEFINE Investigators. (2010) Safety of Anacetrapib in patients with or at a high risk for coronary heart disease. N Engl J Med. 363(25): 2406-2415.
12. Celermajer, D.S. (2010) Wait for weight or "waste" the waist: the benefits of early intervention in childhood obesity. J Am Coll Cardiol 54(25): 2407-2408.
13. Chan, K.H., Chawantanpipat, C., Gattorna, T., Chantadansuwan, T., Kirby, A., Madden, A., Keech, A. and Ng, M.K.(2010) The relationship between coronary stenosis severity and compression type coronary artery movement in acute myocardial infarction. Am Heart J 159 (4): 584-592.
14. Chan, D.C., Hamilton, S.J., Rye, K.A., Chew, G.T., Jenkins, A.J., Lambert, G. and Watts, G.F.(2010) Fenofibrate concomitantly decreases serum proprotoen convertase subtilisin/kexin type 9 and very low density lipoprotein particle concentrations in statin-treated type 2 diabetic patients. Diabetes Obes Metab. 12(9): 752-756.
15. Chow, R.W., Handelsman, D.J. and Ng M.K. (2010) Minireview: Rapid actions of sex steroids in the endothelium. Endocrinology 151(6): 2411-2422.
16. Cohn, J.S., Kamili, A., Wat, E., Chung, R.W. and Tandy, S. (2010) Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications. Atheroscler Suppl 11(1): 45-48.
17. Cordina, R. and Celermajer, D.S. (2010) Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease. Cardiol Young 20(3):242-253.
18. Cordina, R. and Celermajer, D.S. (2010) Late-onset pulmonary arterial hypertension after a sucessful atrial or arterial switch procedure of the great arteries. Pediatr Cardiol 31(2): 238-241.
19. Cordina, R.L. and Celermajer, D.S. (2010) Therapeutic approaches in adults with congenital heart disease associated pulmonary arterial hypertension. Eur Respir Rev. 19(118): 300-307.
20. Davis, J.S., Yeo, T.W., Piera, K.A., Woodberry, T., Celermajer, D.S., Stephens, D.P. and Anstey, N.M. (2010) Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 14(3): R89.
21. de Souza, J.A., Vindis, C., Negre-Salvayre, A., Rye, K.A., Couturier, M., Therond, P., Chantepie, S., Salvayre, R., Chapman, M.J. and Kontush, A. (2010) Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J Cell Mol Med. 14(3): 608-620
22. Dunn, L.L., Buckle, A.M., Cooke, J.P. and Ng, M.K. (2010) The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol. 30(11):2089-2098.
23. Fryirs, M.A., Barter, P.J., Appavaroo, M., Tuch, B.E., Tabet, F., Heather, A.K. and Rye, K.A. (2010) Effects of high-density lipoproteins on pancreatic - cell insulin secretion. Arterioscler Thromb Vasc Biol. 30(8): 1642-1648.
24. Hamdan, R., Mirochnik, N., Celermajer, D., Nassar, P. and Iserin, L. (2010) Cor triatriatum sinister diagnosed in adult life with three dimensional transesophageal echocardiography. BMC Cardiovasc Disord. 10(1): 54.
25. Imaizumi, S., Kiya, Y.,Miura, S., Zhang, B., Matsuo, Y., Uehara, Y., Rye, K.A. and Saku, K. (2010) Pharmacological intervention using reconstituted high-density lipoprotein changes in the lipid profile in spontaneously hypersensitive rats. Clin Exp Hypertens 32(3): 202-208.
26. Ilsar, R., Chawantanpipat, C., Chan, K.H., Dobbins, T.A., Waugh, R., Hennessy, A., Celermajer, D.S. and Ng, M.K. (2010) Doppler-derived pulmonary flow reserve detects pulmonary microvascular obstruction in high primates. Heart Lung Circ. 19(10): 592-594.
27. Ilsar, R., Bailey, B.P., Dobbins, T.A. and Celermajer, D.S. (2010) The relationship between pulmonary artery and pulmonary capillary wedge pressure for the diagnosis of pulmonary vascular disease. Heart Lung Circ 19(1): 38-42.
28. Ilsar, R., Chawantanpipat, C., Chan, K.H., Dobbins, T.A., Waugh, R., Hennessy, A., Celermajer, D.S. and Ng, M.K. (2010) Measurement of pulmonary flow reserve and pulmonary index of microcirculatory resistance for detection of pulmonary microvascular obstruction. PLoS One 5 (3): e9601.
29. Ilsar, R., Levitt, J., Ng, M.K., Kritharides, L., Adams, M.R. and Celermajer, D.S. (2010) Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension. Eur Respir J. 36(6): 1483-1485.
30. Jansson, P.J., Hawkins, C.L., Lovejoy, D.B. and Richardson, D.R. (2010) The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: An EPR study. J Inorg Biochem. 104(11): 1224-1228.
31. Kamili, A., Wat, E., Chung, R.W., Tandy, S., Weir, J.M., Meikle, P.J. and Cohn, J.S. (2010) Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet. supplemented with milk phospholipids. Nutr Metab. 7(1):90.
32. Kennett, E.C., Rees, M.D., Malle, E., Hammer, A., Whitelock, J.M. and Davies, M.J. (2010) Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains. Free Radic Biol Med. 49(2): 282-293.
33. Koelsch, M., Mallak, R., Graham, C.G., Kajer, T., Milligan, M.K., Nguyen, L.Q., Newsham, D.W., Keh, J.S., Kettle, A.J., Scott, K.F., Ziegler, J.B., Pattison, D.I., Fu, S., Hawkins, C.L., Rees, M.D. and Davies, M.J. (2010) Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations. Biochem Pharmacol 79(8): 1156-1164.
34. Lane, A.E., Tan, J.T., Hawkins, C.L., Heather, A.K. and Davies, M.J. (2010) The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages. Biochem J. 430(1): 161-169.
35. Lau, E.M., Yee, B.J., Grunstein, R.R. and Celermajer, D.S. (2010) Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Med Rev 14(6): 391-395.
36. Mackie, F.E. Rosenberg, A.R., Harmer, J.A., Kainer, G. and Celermajer, D.S. (2010) HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study. Acta Paediatr 99(3): 457-459.
37. Moheimani, F., Morgan, P.E., van Reyk, D.M. and Davies, M.J. (2010) Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis. Biochem Biophys Acta. 1802(6): 561-571.
38. Nicholls, S.J., Brandrup-Wognsen, G., Palmer, M. and Barter P.J.(2010) Meta-analysis of comparative efficacy of increasing dose of atovastatin versus rosuvastatin versus simvastatin in lowering levels of atherogenic lipids (from VOYAGER). Am J Cardiol 105(1): 69-76.
39. Nobecourt, E., Tabet, F., Lambert, G., Puranik, R., Bao, S., Yan, L., Davies, M.J., Brown, B.E., Jenkins, A.J., Dusting, G.J., Bonnet, D.J., Curtiss, L.K., Barter, P.J. and Rye, K.A. (2010) Non-enzymatic glycation impairs the anti-inflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol 30 (4): 766-772.
40. Patel, S., Di Bartolo, B.A., Nakhla, S., Heather, A.K., Mitchell, T.W., Jessup, W., Celermajer, D.S., Barter, P.J. and Rye, K.A. (2010) Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis. 212(2): 392-397.
41. Peskin, A.V., Cox, A.G., Nagy, P., Morgan, P.E., Hampton, M.B., Davies, M.J. and Winterbourn, C. (2010) Removal of amino acid, peptide and protein hydro-peroxides by reaction with peroxiredoxins 2 and 3. Biochem J 432(2):313-321.
42. Puranik, R., Muthurangu, V., Celermajer, D.S. and Taylor, A.M. (2010) Congenital heart disease and multi-modality imaging. Heart Lung Circ 19(3): 133-144.
43. Rahmanto, A.S., Morgan, P.E., Hawkins, C.L. and Davies, M.J. (2010) Cellular effects of peptide and protein hydroperoxides. Free Radic Biol Med 48(8): 1071-1078.
44. Rahmanto, A.S., Morgan, P.E., Hawkins, C.L. and Davies, M.J. (2010) Cellular effects of photogenerated oxidants and long-lived, reactive, hydroperoxide photoproducts. Free Radic Biol Med. 49(10): 1505-1515.
45. Roberts, P., Spina, R., Vallely, M., Wlison, M., Bailey, B. and Celermajer, D.S. (2010) Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circ Cardiovasc Interv. 3(4); e14-15.
46. Sieveking, D.P., Chow, R.W. and Ng, M.K. (2010) Androgens, angiogenesis and cardiovascular regeneration. Curr Opin Endocrinol Diabetes Obes. 17(3): 277-283.
47. Sieveking, D.P., Lim, P., Chow, R.W., Dunn, L.L., Bao, S., McGrath, K.C., Heather, A.K., Handelsman, D.J., Celermajer, D.S. and Ng, M.K. (2010) A sex-specific role for androgens in angiogenesis. J Exp Med 207(2):345-352.
48. Spina, R., Forrest, A.P., Adams, M.R., Wilson, M.K., Ng, M.K. and Vallely, M.P. (2010) Veno-Arterial extracorporeal membrane oxygenation for high-risk cardiac catheterisation procedures. Heart Lung Circ. 19(12): 736-741.
49. Stanley, N.R., Pattison, D.I. and Hawkins, C.L.(2010) Ability of hypochlorous acid and N-Chloramines to chlorinate DNA and it's constituents. Chem Res Toxicol. 23(7): 1293-1302.
50. Szuchman-Sapir, A.J., Pattison, D.I., Davies, M.J. and Witting, P.K. (2010) Site-specific hypochlorous acid-induced oxidation of recombinant human myoglobin affects amino acid residues and the rate of cytochrome b5-mediated heme reduction. Free Radic Biol Med 48(1): 35-46.
51. Tandy, S., Chung, R.W., Kamili, A., Wat, E., Weir, J.M., Meike, P.J. and Cohn, J.S. (2010) Hydrogenerated phosphatidylcholine supplementation reduces hepatic lipid levels in mice fed a high-fat diet. Atherosclerosis. 213(1):142-147.
52. Taskinen, M.R., Barter, P.J., Ehnholm, C., Sullivan, D.R., Mann, K., Simes, J., Best, J.D., Hamwood, S. and Keech, A.C.; on behalf of the FIELD study investigators. (2010) Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia. 53(9): 1846-1855.
53. Thornton, C.E., Makris, A., Ogle, R.F., Tooher, J.M. and Hennessy, A. (2010) The role of proteinuria in defining preeclampsia - clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 37(4): 466-470.
54. Thornton, C.E., Makris, A., Tooher, J.M., Ogle, R.F. and Hennessy, A. (2010) Does the anti-hypertensive drug clonidine affect the short-term variation in CTG recordings? Aust NZ J Obstet Gynaecol 50(5): 456-459.
55. Wang, Y., Liu, H., McKenzie, G., Witting, P.K., Stasch, J.P., Hahn, M., Changsirivathanathamrong, D., Wu, B.J., Ball, H.J., Thomas, S.R., Kapoor, V., Celermajer, D.S, Mellor, A.L., Keaney, J.F. Jr., Hunt, N.H. and Stocker, R. (2010) Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 16 (3): 279-285
56. Waterworth, D.M., Ricketts, S.L., Song, K., Chen, L., Zhao, J.H., Ripatti, S., Aulchenko, Y.S., Zhang, W., Yuan, X., Lim, N., Luan, J., Ashford, S., Wheeler, E., Young, E.H., Hadley, D., Thompson, J.R., Braund, P.S., Johnson, T., Struchalin, M., Surakka, I., Luben, R., Khaw, K.T., Rodwell, S.A., Loos, R.J., Boekholdt, S.M., Inouye, M., Deloukas, P., Elliott, P., Schlessinger, D., Sanna, S., Scuteri, A., Jackson, A., Mohlke, K.L., Tuomilehto, J., Roberts, R., Stewart, A., Kesäniemi, Y.A., Mahley, R.W., Grundy, S.M; Wellcome Trust Case Control Consortium, McArdle, W., Cardon, L., Waeber, G., Vollenweider, P., Chambers, J.C., Boehnke, M., Abecasis, G.R., Salomaa, V., Järvelin, M.R., Ruokonen, A., Barroso, I., Epstein, S.E., Hakonarson, H.H., Rader, D.J., Reilly, M.P., Witteman, J.C., Hall, A.S., Samani, N.J., Strachan, D.P., Barter, P., van Duijn, C.M., Kooner, J.S., Peltonen, L., Wareham, N.J., McPherson, R., Mooser, V. and Sandhu, M.S.(2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 30(11)2264-2276.
57. Waterhouse, A., Yin, Y., Wise, S.G., Bax, D.V., McKenzie, D.R., Bilek, M.M., Weiss, A.S. and Ng, M.K. (2010) The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents. Biomaterials. 31(32): 8332-8340.
58. Wilson, A.M., Shin, D.S., Weatherby, C., Harada, R.K., Ng, M.K., Nair, N., Kielstein, J. and Cooke, J.P. (2010) Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. Vasc Med 15(4): 267-274.
59. Wu, B.J., Yan, L., Charlton, F., Witting, P., Barter, P.J. and Rye, K.A. (2010) Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Arterioscler Thromb Vasc Biol 30(5): 968-975.
60. Yeo, T.W., Lampah, D.A., Tjitra, E., Gitawati, R., Darcy, C.J., Jones, C., Kenagalem, E., McNeil, Y.R., Granger, D.L., Lopansri, B.K., Weinberg, J.B., Price, R.N., Duffull, S.B., Celermajer, D.S. and Anstey, N.M. (2010) Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLos Pathog 6(4): e 1000868.